Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Gillespie

Showing results (61-70 of 272) with videos related to

Pageof 28
Sort By:
Neuroreport|May 17, 1996
Neuropeptide Y phase shifts circadian rhythms in vivo via a Y2 receptorK L Huhman, C F Gillespie, C L Marvel, et al.
International Journal of Radiation Oncology, Biology, Physics|April 11, 2019
In Regard to Marcrom et alMichael K Rooney, Jillian R Gunther, Erin F Gillespie, et al.
Journal of Drug Education|January 1, 1988
Predisposition to drug use in rural adolescents: preliminary relationships and methodological considerationsG M Blau, J F Gillespie, R D Felner, et al.
Neuroscience Letters|May 19, 1995
Analysis of the phase shifting effects of gastrin releasing peptide when microinjected into the suprachiasmatic regionH E Albers, C F Gillespie, T O Babagbemi, et al.
Annals of the New York Academy of Sciences|April 24, 1997
Peptidergic mechanisms of action in the suprachiasmatic nucleusK L Huhman, C F Gillespie, C L Marvel, et al.
Neurochemical Research|July 7, 2014
Protein vicinal thiol oxidations in the healthy brain: not so radical links between physiological oxidative stress and neural cell activitiesTimothy D Foley, Kristen M Cantarella, Paul F Gillespie, et al.
Journal of Biological Rhythms|June 1, 1996
Bicuculline increases and muscimol reduces the phase-delaying effects of light and VIP/PHI/GRP in the suprachiasmatic regionC F Gillespie, K L Huhman, T O Babagbemi, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 12, 2016
Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and BeyondVasiliki Michopoulos, Abigail Powers, Charles F Gillespie, et al.
Oncogene|August 9, 2007
Chk2 is required for optimal mitotic delay in response to irradiation-induced DNA damage incurred in G2 phaseM D Rainey, E J Black, G Zachos, et al.
JAMA Network Open|July 17, 2020
Evaluation of Use of Shorter Radiation Regimens for Breast and Prostate Cancer in the US, 2015-2017Erin F Gillespie, Kathryn R Tringale, Peter B Bach, et al.
Pageof 28

Showing results (61-70 of 272) with videos related to

Sort By:
Pageof 28
Neuroreport|May 17, 1996
Neuropeptide Y phase shifts circadian rhythms in vivo via a Y2 receptorK L Huhman, C F Gillespie, C L Marvel, et al.
International Journal of Radiation Oncology, Biology, Physics|April 11, 2019
In Regard to Marcrom et alMichael K Rooney, Jillian R Gunther, Erin F Gillespie, et al.
Journal of Drug Education|January 1, 1988
Predisposition to drug use in rural adolescents: preliminary relationships and methodological considerationsG M Blau, J F Gillespie, R D Felner, et al.
Neuroscience Letters|May 19, 1995
Analysis of the phase shifting effects of gastrin releasing peptide when microinjected into the suprachiasmatic regionH E Albers, C F Gillespie, T O Babagbemi, et al.
Annals of the New York Academy of Sciences|April 24, 1997
Peptidergic mechanisms of action in the suprachiasmatic nucleusK L Huhman, C F Gillespie, C L Marvel, et al.
Neurochemical Research|July 7, 2014
Protein vicinal thiol oxidations in the healthy brain: not so radical links between physiological oxidative stress and neural cell activitiesTimothy D Foley, Kristen M Cantarella, Paul F Gillespie, et al.
Journal of Biological Rhythms|June 1, 1996
Bicuculline increases and muscimol reduces the phase-delaying effects of light and VIP/PHI/GRP in the suprachiasmatic regionC F Gillespie, K L Huhman, T O Babagbemi, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 12, 2016
Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and BeyondVasiliki Michopoulos, Abigail Powers, Charles F Gillespie, et al.
Oncogene|August 9, 2007
Chk2 is required for optimal mitotic delay in response to irradiation-induced DNA damage incurred in G2 phaseM D Rainey, E J Black, G Zachos, et al.
JAMA Network Open|July 17, 2020
Evaluation of Use of Shorter Radiation Regimens for Breast and Prostate Cancer in the US, 2015-2017Erin F Gillespie, Kathryn R Tringale, Peter B Bach, et al.
Pageof 28